A Practice Note addressing the antitrust implications of vertical mergers in the health care industry, such as combinations among hospitals or health systems and physician groups, insurers and health care providers, or insurers and pharmacy benefits management (PBM) companies. This resource discusses the applicable antitrust statutes, the theories of harm that the Department of Justice (DOJ) and Federal Trade Commission (FTC) consider, and recent enforcement actions.